{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:33:13Z","timestamp":1784845993654,"version":"3.55.0"},"reference-count":11,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2015,8]]},"abstract":"New Zealand Blood Service Haemovigilance uses International Society of Blood Transfusion\/International Haemovigilance Network definitions to categorize transfusion reactions (TR<\/jats:styled-content>). Transfusion\u2010associated dyspnoea (TAD<\/jats:styled-content>) is a category for TR<\/jats:styled-content> with respiratory features (TRRF<\/jats:styled-content>) that do not fit definitive entities. TRRF<\/jats:styled-content>, including TAD<\/jats:styled-content>, are clinically significant. TR<\/jats:styled-content> classified as TAD<\/jats:styled-content> were reviewed. We found that many TAD<\/jats:styled-content> may have been transfusion\u2010associated circulatory overload. Better information in TR<\/jats:styled-content> reports and refining TR<\/jats:styled-content> diagnostic criteria may result in less misclassification of TRRF<\/jats:styled-content>. TAD<\/jats:styled-content> may represent mild, atypical or overlap entities, and there may be a residuum of cases with currently unexplained pathophysiology.<\/jats:p>","DOI":"10.1111\/vox.12262","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T02:49:29Z","timestamp":1428547769000},"page":"197-200","source":"Crossref","is-referenced-by-count":17,"title":["Transfusion\u2010associated dyspnoea \u2013 shadow or substance?"],"prefix":"10.1111","volume":"109","author":[{"given":"K. G.","family":"Badami","sequence":"first","affiliation":[{"name":"New Zealand Blood Service Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Joliffe","sequence":"additional","affiliation":[{"name":"New Zealand Blood Service Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stephens","sequence":"additional","affiliation":[{"name":"New Zealand Blood Service Wellington New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"New Zealand Blood Service Haemovigilance Annual Reports. Available at:http:\/\/intranet\/Haemovigilance%20Annual%20Reports.htm(accessed 15th May 2014)"},{"key":"e_1_2_6_3_1","unstructured":"PolitisC Wiersum\u2010OsseltonJC.Update on ISTARE: Recent Findings in Recipients and Future Orientationof the International Database on Haemovigilance. Available at:http:\/\/ihs-seminar.org\/content\/uploads\/Blood-transfusion-abstract-and-papers.pdf(accessed 15th May 2014)"},{"key":"e_1_2_6_4_1","unstructured":"International Society of Blood Transfusion\/International Haemovigilance Network.Proposed Standard Definitions for Surveillance of non Infectious Adverse Transfusion Reactions.2011. Available at:http:\/\/www.isbtweb.org\/fileadmin\/user_upload\/WP_on_Haemovigilance\/ISBT_definitions_final_2011__4_.pdf(accessed 15th May 2014)"},{"key":"e_1_2_6_5_1","unstructured":"Irish Blood Transfusion Service National Haemovigilance Office Report 2010\/2011. Available at:https:\/\/www.giveblood.ie\/Clinical_Services\/Haemovigilance\/Publications\/NHO_Report_2010_2011.pdf(accessed 28th May 2014)"},{"key":"e_1_2_6_6_1","unstructured":"South African National Blood Service and the Western Province Blood Transfusion Service Haemovigilance Report2012. Available at:http:\/\/www.sanbs.org.za\/PDFDocuments\/services\/Haemovigilance\/SANBS%20HV%20Report%202012.pdf(accessed 28th May 2014)"},{"key":"e_1_2_6_7_1","unstructured":"Bolton\u2010MaggsPHB(Ed) PolesD WattA et\u00a0al.On behalf of the Serious Hazards of Transfusion (SHOT) Steering Group.The 2012 Annual SHOT Report(2013). Available at:http:\/\/www.shotuk.org\/wp-content\/uploads\/2013\/08\/SHOT-Annual-Report-2012.pdf(accessed 28th May 2014)"},{"key":"e_1_2_6_8_1","first-page":"17","article-title":"Underreporting of minor transfusion reactions in cancer patients","volume":"6","author":"Narvios AB","year":"2004","journal-title":"MedGenMed"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03247.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs105"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000214311.56231.23"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.04326.x"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvox.12262","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.12262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T17:24:19Z","timestamp":1696008259000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vox.12262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1111\/vox.12262"],"URL":"https:\/\/doi.org\/10.1111\/vox.12262","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}